Cargando…
In vitro activity and In vivo efficacy of Isoliquiritigenin against Staphylococcus xylosus ATCC 700404 by IGPD target
Staphylococcus xylosus (S. xylosus) is a type of coagulase-negative Staphylococcus, which was previously considered as non-pathogenic. However, recent studies have linked it with cases of mastitis in cows. Isoliquiritigenin (ISL) is a bioactive compound with pharmacological functions including antib...
Autores principales: | Qu, Qianwei, Wang, Jinpeng, Cui, Wenqiang, Zhou, Yonghui, Xing, Xiaoxu, Che, Ruixiang, Liu, Xin, Chen, Xueying, Bello-Onaghise, God’spower, Dong, Chunliu, Li, Zhengze, Li, Xiubo, Li, Yanhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924684/ https://www.ncbi.nlm.nih.gov/pubmed/31860659 http://dx.doi.org/10.1371/journal.pone.0226260 |
Ejemplares similares
-
Rutin, A Natural Inhibitor of IGPD Protein, Partially Inhibits Biofilm Formation in Staphylococcus xylosus ATCC700404 in vitro and in vivo
por: Qu, Qianwei, et al.
Publicado: (2021) -
Comparative proteomic analysis reveals drug resistance of Staphylococcus xylosus ATCC700404 under tylosin stress
por: Liu, Xin, et al.
Publicado: (2019) -
Histidine Metabolism and IGPD Play a Key Role in Cefquinome Inhibiting Biofilm Formation of Staphylococcus xylosus
por: Zhou, Yong-hui, et al.
Publicado: (2018) -
Azithromycin Inhibits Biofilm Formation by Staphylococcus xylosus and Affects Histidine Biosynthesis Pathway
por: Ding, Wenya, et al.
Publicado: (2018) -
Discovery of Potential Anti-infective Therapy Targeting Glutamine Synthetase in Staphylococcus xylosus
por: Cui, Wen-Qiang, et al.
Publicado: (2019)